Skip to main content
SpringerLink
Log in

Psoriasis

  • Chapter
Psoriasis and Psoriatic Arthritis

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Arntzen N, Kavli G, Volden G (1984) Psoriasis provoked by beta-blocking agents. Acta Derm Venereol (Stockh) 64: 346–348

    PubMed  CAS  Google Scholar 

  2. Arzensek J, Kansky A, Kavcic C, Pejovnik-Pustinek A, Sturbej S (1984) Epidemiology of psoriasis in the Celje area. Acta Derm Venereol (Stockh) Suppl 113: 106–108

    Google Scholar 

  3. Asboe-Hansen G (1971) Psoriasis in childhood. In: Farber EM, Cox AJ (eds) Psoriasis. Proceedings of the international symposium. Stanford University Press, Stanford, CA, p 53

    Google Scholar 

  4. Ashcroft DM (1999) Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality. Br J Dermatol 141: 185–191

    Article  PubMed  CAS  Google Scholar 

  5. Baker H, Ryan TJ (1968) Generalized pustular psoriasis: a clinical and epidemiological study of 104 cases. Br J Dermatol 80: 771–793

    PubMed  CAS  Google Scholar 

  6. Baker H, Golding DN, Thompson N (1964) The nails in psoriatic arthritis. Br J Dermatol 76: 549–554

    PubMed  CAS  Google Scholar 

  7. Balagon MV, Tan PL, Prestidge R, et al. (2001) Improvement in psoriasis after intradermal administration of dilapidated, deglycolipidated Mycobacterium vaccae (PVAC): results of an open label trial. Clin Exp Dermatol 26: 233–241

    Article  PubMed  CAS  Google Scholar 

  8. Biondi Oriente C, Scarpa R, Pucino A, Oriente P (1989) Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Derm Venereol Suppl 146: 69–71

    CAS  Google Scholar 

  9. Boffetta P, Gridley G, Lindelof B (2001) Cancer risk in a population-based cohort of patients hospitalized for psoriasis in Sweden. J Invest Dermatol 117: 1531–1537

    Article  PubMed  CAS  Google Scholar 

  10. Bowcock AM, Barker JN (2003) Genetics of psoriasis: the potential impact on new therapies. J Am Acad Dermatol Suppl 49: S51–56

    Article  PubMed  Google Scholar 

  11. Braathen LR, Botten G, Bjerkedal T (1989a) Prevalence of psoriasis in Norway. Acta Derm Venereol Suppl 142: 5–8

    CAS  Google Scholar 

  12. Braathen LR, Botten G, Bjerkedal T (1989b) Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venereol Suppl 142: 9–12

    CAS  Google Scholar 

  13. Braegger C, Nicholls S, Murch S, Stephens S, MacDonald T (1992) Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 339: 89–91

    Article  PubMed  CAS  Google Scholar 

  14. Brandrup E, Green A (1981) The prevalence of psoriasis in Denmark. Acta Derm Venereol (Stockh) 61: 344–346

    PubMed  CAS  Google Scholar 

  15. Brockbank J, Gladman D (2002) Diagnosis and management of psoriatic arthritis. Drugs 62: 2447–2457

    PubMed  CAS  Google Scholar 

  16. Buntin DM, Skinner RB, Rosenberg EW (1983) Onset of psoriasis at age 108. J Am Acad Dermatol 9: 276–277

    PubMed  CAS  Google Scholar 

  17. Burch PRJ, Rowell NR (1965) Psoriasis: aetiological aspects. Acta Derm Venereol (Stockh) 45: 366–380

    PubMed  CAS  Google Scholar 

  18. Capon F, Toal IK, Evans JC, et al. (2003) Haplotype identity of distantly related populations implicates corneodesmosin in psoriasis susceptibility. J Med Genet 40: 447–452

    Article  PubMed  CAS  Google Scholar 

  19. Chang YT, Tsai SF, Lee DD, et al. (2003) A study of candidate genes for psoriasis near HLA-C in Chinese patients with psoriasis. Br J Dermatol 148: 418–423

    Article  PubMed  CAS  Google Scholar 

  20. Chaput JC, Poynard T, Naveau S, Penso D, Durrmeyer O, Suplisson D (1985) Psoriasis, alcohol and liver disease. Br Med J 291: 25

    CAS  Google Scholar 

  21. Christophers E (2000) What does epidemiology tell us about disease mechanisms in psoriasis. Clin Exp Dermatol 25: 164

    Article  PubMed  Google Scholar 

  22. Christophers E (2001) Psoriasis — epidemiology and clinical spectrum. Clin Exp Dermatol 26: 314–320

    PubMed  CAS  Google Scholar 

  23. Christophers E, Henseler T (1990) Psoriasis Type I and II are subtypes of nonpustular psoriasis. In: Roenigk HH, Maibach HI (eds) Psoriasis, 2nd edn. Marcel Dekker, New York, pp 15–21

    Google Scholar 

  24. Convit J (1963) Investigation of the incidence of psoriasis among Latin American Indians. In: Proceedings of the 12th International Congress of Dermatology, Washington 1962. International Congress Series No. 55, Excerpta Medica Foundation, Amsterdam

    Google Scholar 

  25. Crow KD, Hargreaves GK (1968) Infantile pustular psoriasis. Trans St. John’s Hosp Dermatol Soc 54: 42

    CAS  Google Scholar 

  26. De Arruda LHF, De Moraes APF (2001) The impact of psoriasis on quality of life. Br J Dermatol 144:Suppl 58: 33–36

    PubMed  Google Scholar 

  27. Devrimici-Ozguven H, Kundakci N, Kumbasar K, Boyvat A (2000) The depression, anxiety, life satisfaction and affective expression levels in psoriasis patients. J Eur Acad Dermatol Venereol 14: 267–271

    Google Scholar 

  28. Duvic M (1991) Papulosquamous disorders associated with human immunodeficiency virus infection. Dermatol Clin 9: 523–530

    Article  PubMed  CAS  Google Scholar 

  29. Eckes L, Ananthakrishnan R, Walter H (1975) Zur geographischen Verteilung der Psoriasis. Hautarzt 26: 563–567

    PubMed  CAS  Google Scholar 

  30. Exum ML, Rapp SR, Feldman SR, et al. (1996) Measuring severity of psoriasis: methodological issues. J Dermatol Treat 7: 119–124

    Google Scholar 

  31. Falk ES, Vandbakk Y (1993) Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol 182: 6–9

    CAS  Google Scholar 

  32. Farber E, Nall LM (1974) The natural history of psoriasis in 5600 patients. Dermatologica 148: 1–18

    Article  PubMed  CAS  Google Scholar 

  33. Farber EM, Nall L (1994) Psoriasis and alcoholism. Cutis 53: 21–27

    PubMed  CAS  Google Scholar 

  34. Farber EM, Bright RD, Nall ML (1968) Psoriasis. A questionnaire survey of 2,144 patients. Arch Dermatol 98: 248

    Article  PubMed  CAS  Google Scholar 

  35. Feldman SR, Fleischer AB, Reboussin DM, et al. (1997) The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 37: 564–569

    PubMed  CAS  Google Scholar 

  36. Ferrandiz C, Bordas X, Garcia Patos V, Puig S, Pujol R, Smandia A (2001) Prevalence of psoriasis in Spain (Epiderma project: phase I). J Eur Acad Dermatol 15: 20–23

    Article  CAS  Google Scholar 

  37. Ferrandiz C, Pujol RM, Garcia-Patos V, Bordas X, Smandia JA (2002) Psoriasis of early and late onset: a clinical and epidemiological study from Spain. J Am Acad Dermatol 46: 867–873

    Article  PubMed  Google Scholar 

  38. Finlay AY, Coles EC (1995) The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 132: 236–244

    PubMed  CAS  Google Scholar 

  39. Food and Drug Administration (1998) Dermatologic and ophthalmic drugs advisory committee 49th meeting (minutes from meeting). March 20, 1998

    Google Scholar 

  40. Fredriksson T, Pettersson U (1978) Severe psoriasis: oral therapy with a new retinoid. Dermatologica 157: 238–244

    PubMed  CAS  Google Scholar 

  41. Frentz G, Olsen JH (1999) Malignant tumors and psoriasis: a follow-up study. Br J Dermatol 140: 237–242

    Article  PubMed  CAS  Google Scholar 

  42. Frentz G, Olsen JH, Avrach WW (1999) Malignant tumours and psoriasis: climatotherapy at the Dead Sea. Br J Dermatol 141: 1088–1091

    Article  PubMed  CAS  Google Scholar 

  43. Geilen CC, Arnold M, Orfanos CE (2001) Mycophenolate mofetil as a systemic antipsoriatic agent: positive experience in 11 patients. Br J Dermatol 144: 583–586

    Article  PubMed  CAS  Google Scholar 

  44. Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ (2003) Lymphoma rates are low but increased in patients with psoriasis — results from a population based cohort study in the United Kingdom. Arch Dermatol 139: 1425–1429

    Article  PubMed  Google Scholar 

  45. Greaves MW, Weinstein GD (1995) Treatment of psoriasis. N Engl J Med 332: 581–588

    Article  PubMed  CAS  Google Scholar 

  46. Gudjonsson JE, Karason A, Antonsdottir AA, et al. (2002) HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 118: 362–365

    Article  PubMed  Google Scholar 

  47. Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B, Kristinsson KG, Valdmiarsson H (2003) Streptococcal throat infections and exacerbation of chronic plaque psoriasis: a prospective study. Br J Dermatol 149: 530–534

    Article  PubMed  CAS  Google Scholar 

  48. Gunawardena DA, Gunawardena KA, Vasanthanathan NS, Gunawardena JA (1978) Psoriasis in Sri Lanka — a computer analysis of 1366 cases. Br J Dermatol 98: 85–96

    PubMed  CAS  Google Scholar 

  49. Gupta MA, Gupta AK (1998) Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 139: 846–850

    PubMed  CAS  Google Scholar 

  50. Habif TP (1996) Psoriasis and other papulosquamous disorders. In: Clinical dermatology: a color guide to diagnosis and therapy, 3rd edn. Mosby-Year Book, St. Louis, pp 190–235

    Google Scholar 

  51. Hammon MG, Reeve CE, Sargent AV, et al. (1977) Psoriasis. In: Bodmer WF, et al. (eds) Histocompatibility testing 1977. Munksgaard, Copenhagen, pp 230–231

    Google Scholar 

  52. Hampe J, Schreiber S, Shaw SH, et al. (1999) A genome wide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet 64: 808–816

    Article  PubMed  CAS  Google Scholar 

  53. Hannuksela M, Karvonen J (1984) Topical trioxsalen PUVA therapy. Acta Derm Venereol (Stockh) Suppl 113: 135–138

    Google Scholar 

  54. Hannuksela-Svahn A, Sigurgeirsson B, Pukkala E, et al. (1999) Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 141: 497–501

    Article  PubMed  CAS  Google Scholar 

  55. Hannuksela-Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J (2001) Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol 117: 1531–1537

    Google Scholar 

  56. Harari M, Shani J, Hristakieva E, et al. (2000) Clinical evaluation of a more rapid and sensitive Psoriasis Assessment Severity Score (PASS), and its comparison with the classic method of Psoriasis Area and Severity Index (PASI), before and after climatotherapy at the Dead Sea. Int J Dermatol 39: 913–918

    PubMed  CAS  Google Scholar 

  57. Hardy GE, Cotterill JA (1982) A study of depression and obsessionality in dysmorphophobic and psoriatic patients. Br J Psychiatry 140: 19–22

    PubMed  CAS  Google Scholar 

  58. Hellgren L (1967) Psoriasis: the prevalence in sex, age, and occupational groups in total populations in Sweden. Morphology, inheritance and association with other skin and rheumatic diseases. Almqvist and Wiskell, Stockholm

    Google Scholar 

  59. Henan Dermatoses Survey Group (1982) An analysis of 487 cases of psoriasis in 100,000 natural population of Henan rural district. Chinese J Dermatol 15: 83–84

    Google Scholar 

  60. Henseler T, Christophers E (1985) Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 13: 340–346

    Google Scholar 

  61. Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32: 982–986

    Article  PubMed  CAS  Google Scholar 

  62. Heydendael VMR, Spuls PI, Opmeer BC, et al. (2003) Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Eng J Med 349: 658–665

    CAS  Google Scholar 

  63. Higgins EM, du Vivier AW (1994a) Alcohol abuse and treatment resistance in skin disease. J Am Acad Dermatol 30: 1048

    Article  PubMed  CAS  Google Scholar 

  64. Higgins EM, du Vivier AW (1994b) Cutaneous disease and alcohol misuse. Br Med Bull 50: 85–98

    PubMed  CAS  Google Scholar 

  65. Holgate MC (1975) The age-of-onset of psoriasis and the relationship to parental psoriasis. Br J Dermatol 92: 443–448

    PubMed  CAS  Google Scholar 

  66. Hughes S, Williams SE, Turnberg LA (1983) Crohn’s disease and psoriasis. N Engl J Med 308: 101

    PubMed  CAS  Google Scholar 

  67. Hugot J, Laurent-Puig P, Gower-Rousseau C, et al. (1996) Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379: 821–823

    Article  PubMed  CAS  Google Scholar 

  68. Inaoki M, Sato S, Shimada Y, et al. (2000) Decreased expression levels of L-selectin on subsets of leucocytes and increased serum L-selectin in severe psoriasis. Clin Exp Immunol 122: 484–492

    Article  PubMed  CAS  Google Scholar 

  69. Karason A, Gudjonsson JE, Upmanyu R, et al. (2003) A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting. Am J Hum Genet 72: 125–131

    Article  PubMed  CAS  Google Scholar 

  70. Kavli G, Forde OH, Arnessen E, Stenvold SE (1985) Psoriasis: familial predisposition and environmental factors. Br Med J (Clin Res Ed) 291: 999–1000

    CAS  Google Scholar 

  71. Kawada A, Tezuka T, Nakamizo Y, et al. (2003) A survey of psoriasis patients in Japan from 1982 to 2001. J Dermatol Sci 31: 59–64

    Article  PubMed  Google Scholar 

  72. Kimball AB, Kawamura T, Tejura K, et al. (2002) Clinical and immunologic assessment of patients with psoriasis in a randomized, double-blind, placebo-controlled trial using recombinant human interleukin 10. Arch Dermatol 138: 1341–1346

    Article  PubMed  CAS  Google Scholar 

  73. Kirby B, Fortune DG, Bhushan M, et al. (2000) The Salford Psoriasis Index: an holistic measure of psoriasis severity. Br J Dermatol 142: 728–732

    PubMed  CAS  Google Scholar 

  74. Kononen M, Torppa J, Lassus A (1986) An epidemiological survey of psoriasis in the Greater Helsinki Area._Acta Derm Venereol 124: 1–10

    CAS  Google Scholar 

  75. Krueger GG, Duvic M (1994) Epidemiology of psoriasis: clinical issues. J Invest Dermatol Suppl 102: 14–18

    Article  Google Scholar 

  76. Krueger GG, Feldman SR, Camisa C, et al. (2000) Two considerations for patients with psoriasis and their clinicians:What defines mild, moderate and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol 43: 281–285

    PubMed  CAS  Google Scholar 

  77. Krueger G, Koo J, Lebwohl M, Menter A, Stern R, Rolstad T (2001) The impact of psoriasis on quality of life. Results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 137: 280–284

    PubMed  CAS  Google Scholar 

  78. Kundakci N, Tursen U, Babiker MOA, Gurgey E (2002) The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients. Int J Dermatol 41: 220–224

    PubMed  Google Scholar 

  79. Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CEM (2003a) An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol 139: 719–727

    Article  PubMed  CAS  Google Scholar 

  80. Lebwohl M, Tyring SK, Hamilton TK, et al. (2003b) A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Eng J Med 349: 2004–2013

    Article  CAS  Google Scholar 

  81. Lee F, Bellary S, Francis C (1990) Increased occurrence of psoriasis in patients with Crohn’s disease and their relatives. Am J Gastroenterol 85: 962–963

    PubMed  CAS  Google Scholar 

  82. Leonardi CL, Powers JL, Matheson RT, et al. (2003) Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349: 2014–2022

    Article  PubMed  CAS  Google Scholar 

  83. Lindelof B, Eklund G, Liden S, Stern RS (1990) The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 22: 1056–1060

    Article  PubMed  CAS  Google Scholar 

  84. Lindelof B, Sigurgeirsson B, Tegner E, et al. (1991) PUVA and cancer: a large scale epidemiological study. Lancet 338: 91–93

    Article  PubMed  CAS  Google Scholar 

  85. Lindelof B, Sigurgeirsson B, Tegner E, Larko O, Berne B (1992) Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. Arch Dermatol 128: 1341–1344

    Article  PubMed  CAS  Google Scholar 

  86. Lindelof B, Sigurgeirson B, Tegner E, et al. (1999) PUVA and cancer risk: the Swedish follow-up study. Br J Dermatol 141: 108–112

    Article  PubMed  CAS  Google Scholar 

  87. Lomholt G (1963) Psoriasis: Prevalence, spontaneous course and genetics. A census study on the prevalence of skin diseases in the Faroe Islands. GEC Gad, Copenhagen

    Google Scholar 

  88. MacLennan A, Hellier FF (1961) The treatment time in psoriasis. Br J Dermatol 73: 439–444

    PubMed  CAS  Google Scholar 

  89. Margolis D, Bilker W, Hennessy S, Vittorio C, Santanna J, Strom BL (2001) The risk of malignancy associated with psoriasis. Arch Dermatol 137: 778–783

    PubMed  CAS  Google Scholar 

  90. Martin BA, Chalmers RJ, Telfer NR (1996) How great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol 132: 717–718

    PubMed  CAS  Google Scholar 

  91. Mills CM, Srivastava ED, Harvey IM, Swift GL, Newcombe RG, Holt PJ, Rhodes J (1992) Smoking habits in psoriasis: a case controlled study. Br J Dermatol 127: 18–21

    PubMed  CAS  Google Scholar 

  92. Moll JMA, Haslock I, Macrae MB, et al. (1974) Associations between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies and Behçet’s syndrome. Medicine 53: 343–362

    PubMed  CAS  Google Scholar 

  93. Morris A, Rogers M, Fischer G, Williams K (2001) Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 18: 188–198

    Article  PubMed  CAS  Google Scholar 

  94. Murch S, Braegger C, Walker-Smith J, MacDonald T (1993) Location of tumor necrosis factor-alpha by immunohistochemistry in chronic inflammatory bowel disease. Gut 34: 1705–1709

    PubMed  CAS  Google Scholar 

  95. Murphy FR, Stolman LP (1979) Generalized pustular psoriasis. Arch Dermatol 115: 1215–1216

    Article  PubMed  CAS  Google Scholar 

  96. Nair R, Henseler T, Jenisch S, Stuart P, Bichakjian C, Lenk W (1997) Evidence for 2 psoriasis susceptibility loci (HLA and 17q) and 2 novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet 6: 1349–1356

    Article  PubMed  CAS  Google Scholar 

  97. Nair RP, Stuart P, Henseler T, et al. (2000) Localization of psoriasis-susceptibility locus PSOR1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66: 1833–1844

    Article  PubMed  CAS  Google Scholar 

  98. Naldi L, Parazzini F, Brevi A, et al. (1992) Family history, smoking habits, alcohol consumption and risk of psoriasis. Br J Dermatol 127: 212–217

    PubMed  CAS  Google Scholar 

  99. Naldi L, Svensson A, Diepgen T, et al. (2003) Randomized clinical trials for psoriasis 1977–2000; the EDEN survey. J Invest Dermatol 120: 738–741

    Article  PubMed  CAS  Google Scholar 

  100. Nall ML, Farber EM (1977) World epidemiology in psoriasis. In: Farber EM, Cox AJ (eds) Psoriasis: Proceedings of the Second International Symposium. Yorke Medical Books, New York, pp 331–333

    Google Scholar 

  101. Nanda A, Kaur S, Kaur I, Kumar B (1990) Childhood psoriasis: an epidemiologic survey of 112 patients. Pediatr Dermatol 7: 19–21

    PubMed  CAS  Google Scholar 

  102. National Institute of Arthritis and Musculoskeletal and Skin Diseases Data (2002) Accessed Dec 5, 2003; last updated January 2002. Available from: URL: http: //www.niams.nih.gov/hi/topics/psoriasis/psoriafs.htm

    Google Scholar 

  103. National Psoriasis Foundation Data (2003) Accessed Dec 5, 2003; last updated 2003. Available from: URL: http://www.psoriasis.org/facts/psoriasis

    Google Scholar 

  104. Nevitt GJ, Hutchinson PE (1996) Psoriasis in the community: prevalence, severity and patients’ beliefs and attitudes towards the disease. Br J Dermatol 135: 533–537

    Article  PubMed  CAS  Google Scholar 

  105. Nickoloff B, Karabin G, Barker J, et al. (1991) Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138: 129–140

    PubMed  CAS  Google Scholar 

  106. Nijsten TEC, Stern RS (2003) The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol 121: 252–258

    Article  PubMed  CAS  Google Scholar 

  107. Nyfors A, Lemholt K (1975) Psoriasis in children. Br J Dermatol 92: 437–442

    PubMed  CAS  Google Scholar 

  108. O’Doherty CJ, Macintyre C (1985) Palmoplantar pustulosis and smoking. BMJ 291: 861–864

    PubMed  CAS  Google Scholar 

  109. Ojetti V, Sanchez JA, Guerriero C, Fossati B, Capizzi R, De Simone C, et al. (2003) High prevalence of celiac disease in psoriasis. Am J Gastroenterol 98: 2574–2575

    Article  PubMed  CAS  Google Scholar 

  110. Paljan D, Kansky A, Cividini-Stranic E (1984) Psychosomatic factors influencing the course of psoriasis. Acta Derm Venereol (Stockh) Suppl 113: 121–122

    Google Scholar 

  111. Papp K, Bissonnette R, Krueger JG, et al. (2001) The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody. J Am Acad Dermatol 45: 665–674

    Article  PubMed  CAS  Google Scholar 

  112. Poikolainen K, Reunala T, Karvonen J, Lauharanta J, Karkkainen P (1990) Alcohol intake: a risk factor for psoriasis in young and middle aged men? BMJ 300: 780–783

    Article  PubMed  CAS  Google Scholar 

  113. Poikolainen K, Reunala T, Karvonen J (1994) Smoking, alcohol and life events related to psoriasis among women. Br J Dermatol 130: 473–477

    PubMed  CAS  Google Scholar 

  114. Rea JN, Newhouse ML, Halil T (1976) Skin disease in Lambeth: a community study of prevalence and use of medical care. Br J Prev Soc Med 30: 107–114

    PubMed  CAS  Google Scholar 

  115. Ryan TJ, Baker H (1969) Systemic corticosteroids and folic acid antagonists in the treatment of generalized pustular psoriasis. Evaluation and prognosis based on the study of 104 cases. Br J Dermatol 81: 134–145

    PubMed  CAS  Google Scholar 

  116. Scarpa R, Oriente P, Pucino A, et al. (1984) Psoriatic arthritis in psoriatic patients. Br J Rheum 23: 246–250

    CAS  Google Scholar 

  117. Scharloo M, Kaptein AA, Weinman J, Bergman W, Vermeer BJ, Rooijmans HGM (2000) Patients’ illness perceptions and coping as predictors of functional status in psoriasis: a 1-year follow-up. Br J Dermatol 142: 899–907

    Article  PubMed  CAS  Google Scholar 

  118. Shao CG, Zhang FW, Wang KC (1987) The distribution of psoriasis. A nationwide screening in the People’s Republic of China, 1984. In: Farber EM, Nall L, Morhenn V, Jacobs PH (eds) Psoriasis. Proceedings of the Fourth International Symposium, Elsevier, New York, pp 398–399

    Google Scholar 

  119. Shbeeb M, Uramoto KM, Gibson LE, et al. (2000) The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 27: 1247–1250

    PubMed  CAS  Google Scholar 

  120. Sigmundsdottir H, Gudjonsson JE, Jonsdottir I, et al. (2001) The frequency of CLA+ CD8+ T cells in the blood of psoriasis patients correlates closely with the severity of their disease. Clin Exp Immunol 126: 365–369

    Article  PubMed  CAS  Google Scholar 

  121. Smith AE, Kassab JY, Payne RCME, Beer WE (1993) Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 186: 181–186

    PubMed  CAS  Google Scholar 

  122. Snellman E, Lauharanta J, Revnanen A, et al. (1993) Effect of heliotherapy on skin in psoriasis: a 6-month follow up study. Br J Dermatol 128: 172–177

    PubMed  CAS  Google Scholar 

  123. Stern RS (1985) The epidemiology of joint complaints in patients with psoriasis. J Rheumatol 12: 315–320

    PubMed  CAS  Google Scholar 

  124. Stern RS, Vakeva LH (1997) Noncutaneous malignant tumors in the PUVA follow-up study: 1975-1996. J Invest Dermatol 108: 897–900

    Article  PubMed  CAS  Google Scholar 

  125. Stern RS, Liebman EJ, Vakeva L (1998) Oral psoralen and ultraviolet A light (PUVA) treatment of psoriasis and persistent risk of non-melanoma skin cancer. PUVA follow-up study. J Natl Cancer Inst 90: 1278–1284

    Article  PubMed  CAS  Google Scholar 

  126. Swanbeck G, Inerot A, Martinsson T, et al. (1995) Age of onset and different types of psoriasis. Br J Dermatol 133: 768–773

    PubMed  CAS  Google Scholar 

  127. Tagami H (1997) Triggering factors. Clin Dermatol 15: 677–685

    PubMed  CAS  Google Scholar 

  128. Thaci D, Brautigam M, Kaufmann R, et al. (2002) Body-weight independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. Dermatology 205: 383–388

    PubMed  CAS  Google Scholar 

  129. Tiwari JL, Lowe NJ, Abramovits J, et al. (1982) Association of psoriasis with HLA-DR7. Br J Dermatol 106: 227–230

    PubMed  CAS  Google Scholar 

  130. Tomfohrde J, Silverman A, Barnes R, et al. (1994) Gene for familial psoriasis susceptibility mapped to the distal end of chromosome 17Q. Science 264: 1141–1145

    PubMed  CAS  Google Scholar 

  131. Trembath RC, Clough RL, Rosbotham JL, et al. (1997) Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 6: 813–820

    Article  PubMed  CAS  Google Scholar 

  132. Van de Kerkhof PCM (1997) The PASI and alternative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol 137: 661–662

    PubMed  Google Scholar 

  133. Vincenti GE, Blunden SM (1987) Psoriasis and alcohol abuse. J R Army Med Corps 133: 77–78

    PubMed  CAS  Google Scholar 

  134. Wainwright NJ, Dawe RS, Ferguson J (1998) Narrowband ultraviolet B (TL-01) phototherapy for psoriasis: which incremental regimen? Br J Dermatol 139: 410–414

    Article  PubMed  CAS  Google Scholar 

  135. Wakefield P, James W, Sallaska C, Meltzer M (1991) Tumor necrosis factor. J Am Acad Dermatol 24: 675–685

    Article  PubMed  CAS  Google Scholar 

  136. Watson W, Cann HM, Farber EM, Nall ML (1972) The genetics of psoriasis. Arch Dermatol 105: 197–207

    Article  PubMed  CAS  Google Scholar 

  137. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ (2002) Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 47: 512–518

    Article  PubMed  Google Scholar 

  138. Williams RC, McKenzie AW, Roger JH, Joysey VC (1976) HL-A antigens in patients with guttate psoriasis. Br J Dermatol 95: 163–167

    PubMed  CAS  Google Scholar 

  139. Wolf R, Wolf D, Ruocco V (1999) Alcohol intake and psoriasis. Clin Dermatol 17: 423–430

    PubMed  CAS  Google Scholar 

  140. Yasuda T, Ishikawa E, Mori S (1971) Psoriasis in the Japanese. In: Farber EM, Cox AJ (eds) Psoriasis: proceedings of an international symposium. Stanford University Press, Stanford, CA, pp 25–34

    Google Scholar 

  141. Yasuda T, Ito M, Mizuno A, et al. (1976) Internal factors and pustular psoriasis. In: Farber EM, Cox AJ (eds) Psoriasis. Proceedings of the Second International Symposium. Yorke Medical Books, New York, pp 140–145

    Google Scholar 

  142. Yates VM, Watkinson G, Kelman A (1982) Further evidence of an association between psoriasis, Crohn’s disease and ulcerative colitis. Br J Dermatol 106: 323–330

    PubMed  CAS  Google Scholar 

  143. Yip SY (1984) The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 10: 965–968

    Article  PubMed  CAS  Google Scholar 

  144. Zachariae H, Zachariae R, Blomquist K, et al. (2002) Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 82: 108–113

    PubMed  Google Scholar 

  145. Zaias N (1969) Psoriasis of the nail. A clinical pathological study. Arch Dermatol 99: 567–579

    PubMed  CAS  Google Scholar 

  146. Zanolli MD, Wikle JS (1992) Joint complaints in psoriasis patients. Int J Dermatol 31: 488–491

    PubMed  CAS  Google Scholar 

  147. Zonneveld IM, Meinardi MM, Karlsmark T, et al. (1997) Ranitidine does not affect psoriasis: a multicenter, double-blind, placebo-controlled study. J Am Acad Dermatol 36: 932–934

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA

    Christine C. Jacobson AB

  2. Dermatology Clinical Studies Unit, Massachusetts General and Brigham and Women’s Hospitals, Boston, MA, USA

    Alexa B. Kimball MD, MPH

Authors
  1. Christine C. Jacobson AB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alexa B. Kimball MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Dermatology, Loyola University, Stritch School of Medicine, 2160 S. First Ave., Building 112, Room 342, Maywood, IL, 60153, USA

    Kenneth B. Gordon MD

  2. Division of Rheumatology, Northwestern University, Feinberg School of Medicine, 675 N. St. Clair St., Chicago, IL, 60611, USA

    Eric M. Ruderman MD

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Jacobson, C.C., Kimball, A.B. (2005). Psoriasis. In: Gordon, K.B., Ruderman, E.M. (eds) Psoriasis and Psoriatic Arthritis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27190-2_6

Download citation

  • DOI: https://doi.org/10.1007/3-540-27190-2_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-21280-5

  • Online ISBN: 978-3-540-27190-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation